June 30, 2010

BAXTER INTERNATIONAL: To Appeal US$500 Million Profopol Ruling

COMPANIES:
Subscribe

Baxter International Inc. disclosed in its latest quarterly report on Form 10-Q filed with the U.S. Securities and Exchange Commission that the company and Teva Pharmaceuticals USA, Inc. (Teva) intends to appeal a US$500 million adverse decision in Nevada.

The company…

TO CONTINUE READING,LOGIN or
TOPICS: Earnings | Legal Issues, Litigation | Loans & Financing | SEC-Qtrly, Annual Reports | Securities & Exch Comm, US
LOCATIONS: